Hoersholm, 2014-08-27 12:02 CEST (GLOBE NEWSWIRE) --
Company announcement No 37/2014
Chr. Hansen Holding A/S plans to release its financial results and to hold its Annual General Meeting for the financial year 2014/15 on the following dates:
2015
21 January Interim Report (Q1 2014/15)
9 April Interim Report (Q2 2014/15)
1 July Interim Report (Q3 2014/15)
21 October Annual Report 2014/15
26 November Annual General Meeting
Please note that subjects and proposals that shareholders wish to be addressed at the Annual General Meeting will be added to the agenda if such a request is submitted to the Board of Directors no later than on Wednesday, 14 October at 16.00 CET.
For further information, please contact:
Anders Mohr Christensen, Senior Director, Investor Relations
Tel: +45 4574 7618
About Chr. Hansen
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2012/13 financial year was EUR 738 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen. For further information, please visit www.chr-hansen.com.
